# Kyong Ran Peck

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kyong-ran-peck/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,611 |
| Field | Antibiotic Resistance in Bacteria |
| h-index | 66 |
| i10-index | 334 |
| Last Known Institution | Samsung Medical Center |
| OpenAlex ID | https://openalex.org/A5001531905 |
| ORCID iD | https://orcid.org/0000-0002-7464-9780 |
| Works | 571 |

## Researcher papers

- [Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial](https://scholariq.org/papers/rezafungin-versus-caspofungin-for-treatment-of-candidaemia-and-invasive/)

## Researcher topics

- [Antibiotic Resistance in Bacteria](https://scholariq.org/topics/antibiotic-resistance-in-bacteria/)
- [Antimicrobial Resistance in Staphylococcus](https://scholariq.org/topics/antimicrobial-resistance-in-staphylococcus/)
- [Bacterial Identification and Susceptibility Testing](https://scholariq.org/topics/bacterial-identification-and-susceptibility-testing/)
- [Antibiotics Pharmacokinetics and Efficacy](https://scholariq.org/topics/antibiotics-pharmacokinetics-and-efficacy/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

## Researcher university

- [Samsung Medical Center](https://scholariq.org/institutions/samsung-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
